EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Elevated serum galectin‐3 levels predict the incidence of type 2 diabetes mellitus in a Japanese general population: A 10‐year follow‐up study

Harumi Takubo-Yoshimura iD, Mika Enomoto, Ako Fukami, Nagisa Morikawa iD, Yume Nohara-Shitama, Hiromi Sato, Mayo Shimoyama-Yamamoto, Hisashi Adachi, Yoshihiro Fukumoto

Journal of Diabetes Investigation · 2026

DOI: 10.1111/jdi.70326 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Diabetes Investigation, 2026. Verfasst von Harumi Takubo-Yoshimura und 8 weiteren Autor:innen. Beteiligte Einrichtung: Division of Cardio-Vascular Medicine, Department of Internal Medicine, Kurume University School of Medicine, Kurume, Japan. Hauptthemen laut MEDLINE: Diabetes Mellitus, Type 2, Biomarkers, Galectin 3, Galectins. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 34 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Kurume University for the Promotion of Female Researchers.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aims/Introduction Although several studies have reported elevated serum galectin‐3 levels in type 2 diabetes mellitus, its association with type 2 diabetes mellitus, in Japan, where obesity is relatively uncommon, remains unclear. We investigated whether serum galectin‐3 levels can be a predictive marker for type 2 diabetes mellitus in a Japanese general population. Materials and methods A total of 433 participants who underwent a health check‐up in Nagasaki between 2013 and 2014 were enrolled; of these, 307 participants completed follow‐up by 2023. Participants were classified into quartiles based on serum galectin‐3 levels measured by a sandwich enzyme immunoassay, and multivariate logistic regression analysis was performed.

Results

The serum galectin‐3 levels were associated with type 2 diabetes mellitus prevalence ( P = 0.002) in the regression analysis. Over the 10‐year follow‐up, the highest galectin‐3 quartile had a higher type 2 diabetes mellitus incidence than the lowest galectin‐3 quartile (adjusted odds ratio: 5.75; 95% confidence interval: 1.08–30.65). Subgroup analysis stratified by body mass index revealed that each 1‐standard deviation increase in serum galectin‐3 level was associated with a significantly increased risk of incident type 2 diabetes mellitus in the low body mass index group, but not in the high body mass index group.

Conclusions

The serum galectin‐3 levels were significantly associated with type 2 diabetes mellitus prevalence and incidence in a general Japanese population, particularly among individuals without obesity. Galectin‐3 may be a useful biomarker for identifying individuals at risk of type 2 diabetes mellitus.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Diabetes Mellitus, Type 2BiomarkersGalectin 3GalectinsHumansFemaleFollow-Up StudiesJapanMaleIncidenceMiddle AgedPrognosisAgedBody Mass IndexAdultRisk FactorsEast Asian PeopleBlood Proteins

Stichwörter der Autor:innen

galectin‐3obesitytype 2 diabetes mellitus

Substanzen

BiomarkersGalectin 3GalectinsLGALS3 protein, humanBlood Proteins

Autor:innen und Institutionen

  • Division of Cardio-Vascular Medicine, Department of Internal Medicine, Kurume University School of Medicine, Kurume, Japan.
  • Department of Sports Medicine and Science, Faculty of Human Health, Kurume University, Kurume, Japan.
  • Preventive Health and Screening Center, Kurume University Hospital, Kurume, Japan.
  • Department of Community Medicine, Kurume University School of Medicine, Kurume, Japan.
  • Keikokai, Hara Hospital, Fukuoka, Japan.

ORCID-Profile: Harumi Takubo-Yoshimura, Nagisa Morikawa

Förderung

  • Kurume University for the Promotion of Female Researchers

Zitieren

APA

Takubo-Yoshimura, H., Enomoto, M., Fukami, A., Morikawa, N., Nohara-Shitama, Y., Sato, H., Shimoyama-Yamamoto, M., Adachi, H., & Fukumoto, Y. (2026). Elevated serum galectin‐3 levels predict the incidence of type 2 diabetes mellitus in a Japanese general population: A 10‐year follow‐up study. Journal of Diabetes Investigation. https://doi.org/10.1111/jdi.70326

Vancouver

Takubo-Yoshimura H, Enomoto M, Fukami A, Morikawa N, Nohara-Shitama Y, Sato H, et al. Elevated serum galectin‐3 levels predict the incidence of type 2 diabetes mellitus in a Japanese general population: A 10‐year follow‐up study. Journal of Diabetes Investigation. 2026. doi:10.1111/jdi.70326

BibTeX
@article{TakuboYoshimura2026,
  author = {Takubo-Yoshimura, Harumi and Enomoto, Mika and Fukami, Ako and Morikawa, Nagisa and Nohara-Shitama, Yume and Sato, Hiromi and Shimoyama-Yamamoto, Mayo and Adachi, Hisashi and Fukumoto, Yoshihiro},
  title = {Elevated serum galectin‐3 levels predict the incidence of type 2 diabetes mellitus in a Japanese general population: A 10‐year follow‐up study},
  journal = {Journal of Diabetes Investigation},
  year = {2026},
  doi = {10.1111/jdi.70326}
}
Kostenlos starten →